SyntheX Company
SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.
Founded Date:
2016
Employee Number:
11-50
Funding Status:
Seed
Technology:
Cancer
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Estimated Revenue:
$1M to $10M